This Could Send Ozempic's Sales Potential to a Whole Other Level
28/7 12:40
Novo Nordisk (NYSE: NVO) has become one of the most valuable healthcare stocks in the world due in large part to Ozempic, its diabetes drug that has also been effective in helping people lose weight. One challenge for investors and analysts, however, is predicting just how much r...